In addition to inhibiting apoptosis, IL6 signaling is also known to promote migration and invasion in a great variety of tumors including ovarian cancer, breast cancer, glioblastoma and chondrosarcoma [19–22]. This evidence concerns the gene IL6 and breast cancer.